Preliminary Results of Coxsackievirus With Pembrolizumab In Advanced Melanoma

Video

Ann W. Silk, MD, discusses preliminary results of the CAPRA trial, a phase 1B study of intratumoral coxsackievirus A21 (CVA21; CAVATAK) and systemic pembrolizumab in patients with advanced melanoma.

Related Videos
Related Content